title: Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?
authors.forename: Jean
authors.initials: J
authors.lastname: El-Cheikh
authors.forename: Roberto
authors.initials: R
authors.lastname: Crocchiolo
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Boher
authors.forename: Sabine
authors.initials: S
authors.lastname: Fürst
authors.forename: Anne Marie
authors.initials: AM
authors.lastname: Stoppa
authors.forename: Catherine
authors.initials: C
authors.lastname: Faucher
authors.forename: Luca
authors.initials: L
authors.lastname: Castagna
authors.forename: Angela
authors.initials: A
authors.lastname: Granata
authors.forename: Claire
authors.initials: C
authors.lastname: Oudin
authors.forename: Jean-Marc Schiano
authors.initials: JM
authors.lastname: De Colella
authors.forename: Diane
authors.initials: D
authors.lastname: Coso
authors.forename: Reda
authors.initials: R
authors.lastname: Bouabdallah
authors.forename: Mohamad
authors.initials: M
authors.lastname: Mohty
authors.forename: Didier
authors.initials: D
authors.lastname: Blaise
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008495:Medical Oncology / Q000379:methods; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D012306:Risk; D033581:Stem Cell Transplantation / Q000379:methods; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D008558:Melphalan